Linda McMahon, the former wrestling executive now nominated for education secretary, faced questions from senators about how ...
FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including ...
FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including a 67.4% increase in the Rare Diseases portfolio, 9.2% ...
Solid 2024 performance; executing on plan to accelerate growth ...